These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 1676084)
41. CBF changes during headache-free periods and spontaneous/induced attacks in migraine with and without aura: a TCD and SPECT comparison study. De Benedittis G; Ferrari Da Passano C; Granata G; Lorenzetti A J Neurosurg Sci; 1999 Jun; 43(2):141-6; discussion 146-7. PubMed ID: 10735768 [TBL] [Abstract][Full Text] [Related]
42. Sumatriptan in acute migraine: pharmacology and review of world experience. Peroutka SJ Headache; 1990; 30 Suppl 2():554-60. PubMed ID: 2177047 [TBL] [Abstract][Full Text] [Related]
43. Sumatriptan in migraine. Pearce JM BMJ; 1991 Dec; 303(6816):1491. PubMed ID: 1664268 [No Abstract] [Full Text] [Related]
46. [Migraine and sumatriptan]. Stovner LJ Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2384-5. PubMed ID: 8397451 [No Abstract] [Full Text] [Related]
47. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. Eur Neurol; 1991; 31(5):314-22. PubMed ID: 1653139 [TBL] [Abstract][Full Text] [Related]
48. [Migraine crisis: current physiopathological and therapeutic aspects]. Schoenen J; Bastings E Rev Med Liege; 1991 Aug; 46(8):424-34. PubMed ID: 1656508 [No Abstract] [Full Text] [Related]
49. The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Lassen LH; Christiansen I; Iversen HK; Jansen-Olesen I; Olesen J Cephalalgia; 2003 Nov; 23(9):877-86. PubMed ID: 14616929 [TBL] [Abstract][Full Text] [Related]
50. Sumatriptan and recurrence of migraine. Blau JN Lancet; 1992 Oct; 340(8827):1110. PubMed ID: 1357514 [No Abstract] [Full Text] [Related]
51. Sumatriptan: efficacy and contribution to migraine mechanisms. Pearce JM J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041 [No Abstract] [Full Text] [Related]
52. Abnormal photoreactivity in ictal migraine: reversal by sumatriptan. Anzola GP; Magoni M; Dalla Volta G Headache; 1993 Sep; 33(8):417-20. PubMed ID: 7903290 [TBL] [Abstract][Full Text] [Related]
53. Sumatriptan and cerebral perfusion in healthy volunteers. Scott AK; Grimes S; Ng K; Critchley M; Breckenridge AM; Thomson C; Pilgrim AJ Br J Clin Pharmacol; 1992 Apr; 33(4):401-4. PubMed ID: 1315562 [TBL] [Abstract][Full Text] [Related]
54. Psychological status during migraine attack and interval before and after treatment with a selective 5-HT1-agonist. Göbel H; Krapat S Headache; 1993 Mar; 33(3):118-20. PubMed ID: 8387474 [TBL] [Abstract][Full Text] [Related]
56. [Positron emission tomographic studies of migraine]. Géraud G; Denuelle M; Fabre N; Payoux P; Chollet F Rev Neurol (Paris); 2005 Jul; 161(6-7):666-70. PubMed ID: 16141953 [TBL] [Abstract][Full Text] [Related]
57. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294 [TBL] [Abstract][Full Text] [Related]
58. Sumatriptan and recurrence of migraine. Lloyd DK; Pilgrim AJ Lancet; 1992 Oct; 340(8827):1110. PubMed ID: 1357515 [No Abstract] [Full Text] [Related]
59. Spontaneous oscillations in cerebral blood flow velocity give evidence of different autonomic dysfunctions in various types of headache. Sliwka U; Harscher S; Diehl RR; van Schayck R; Niesen WD; Weiller C Headache; 2001 Feb; 41(2):157-63. PubMed ID: 11251700 [TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response. Visser WH; Burggraaf J; Muller LM; Schoemaker RC; Fowler PA; Cohen AF; Ferrari MD Clin Pharmacol Ther; 1996 Oct; 60(4):452-60. PubMed ID: 8873693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]